ENTITY
BeOne

BeOne (ONC US)

166
Analysis
Health Care • China
BeiGene, Ltd. operates as a commercial stage biopharmaceutical company. The Company focuses on discovery, development, and commercialization of molecularly targeted and immuno-oncology drugs for the treatment of cancer. BeiGene serves patients worldwide.
more
•01 Nov 2018 14:21

Innovent Biologics (äæ”č¾¾ē”Ÿē‰©) Post IPO: Hit Our TP, What's Next?

Innovent Biologics was priced at theĀ highĀ end and itĀ started trading yesterday (November 1st). It traded up by 18.5% on the first day and 8% on the...

Logo
822 Views
Share
•31 Oct 2018 16:39

Innovent Biologics IPO First-Day: Take Money off the Table

Despite a recentĀ spell of lacklustre early-stage biotech flotations that have slumpedĀ post-IPO, Innovent Biologics Inc (1801 HK)'s shares popped...

Logo
672 Views
Share
bearish•Babytree Group
•27 Oct 2018 16:59

Last Week in GER Research: A Dancing Tesla, Babytree, Mobvista, TuanChe and Pintec

Below is a recap of the key IPO and event-driven research produced by the Global Equity Research team. This week we recap on polarizedĀ Tesla Motors...

Logo
502 Views
Share
bearish•Tencent
•20 Oct 2018 19:18

Last Week in GER Research: Tencent Backed IPOs, Niu, Innovent Biologics, Babytree and Fujifilm

Below is a recap of the key IPO and event-driven research produced by the Global Equity Research team. This week we highlight a very differentiated...

Logo
748 Views
Share
•16 Oct 2018 17:18

Innovent Biologics (äæ”č¾¾ē”Ÿē‰©) IPO:Ā Limited Upside Despite Strong Cornerstones (Part 3)

Innovent BiologicsĀ launched theĀ institutional book building today and intends to raise USD 377 to USD 423 million, with an implied market...

Logo
525 Views
Share
x